New study finds HPV vaccination cuts cancer risk in boys and young men

11 articles · Updated · CNN · Apr 24

The study, published in JAMA Oncology, analyzed over 615,000 vaccinated males aged 9–26 and 2 million unvaccinated, showing a 46% reduction in HPV-related cancer risk among those vaccinated.
Benefits were observed across age groups, with those vaccinated between 9–14 years seeing a 42% lower risk and those 15–26 years a 50% lower risk.
Experts emphasize HPV vaccination for boys as well as girls, noting its strong safety profile and effectiveness in preventing multiple cancers, and recommend catch-up vaccination through age 26.

Amid conflicting federal and pediatric advice, is one HPV shot enough for boys?

The HPV vaccine cuts cancer risk in half for men, so why are they still left behind?

I'm over 18; is it too late for the HPV vaccine to protect me?

Could a single-dose HPV vaccine strategy backfire in the global fight against cancer?

With throat cancer now the top HPV-related cancer, is vaccination our only defense?

Why did federal health officials bypass their own scientists on HPV vaccine guidance?